Skip to main content

Table 5 Hearing loss (dB) 3 months post first fitting compared to baseline: results of the analysis of the primary endpoint—PP set

From: Randomized placebo-controlled clinical trial investigating the effect of antioxidants and a vasodilator on overall safety and residual hearing preservation in cochlear implant patients

 

Estimate

Standard error

p value

95% confidence interval

ACEMg - placebo

− 8.01

7.4323051

0.2961

(− 23.69, 7.67)

Surgeon 2 - other surgeon

− 1.29

9.7399943

0.8963

(− 21.84, 19.26)

Flex 24 - Flex 20

26.40

15.9253500

0.1157

(− 7.20, 60.00)

Flex 28 - Flex 20

32.73

19.8918623

0.1182

(− 9.23, 74.70)

Flex 28 - Flex 24

6.33

10.5704737

0.5569

(− 15.97, 28.64)

Baseline

− 0.28

0.3292886

0.4037

(− 0.98, 0.41)